Centene Corp Files 8-K for Regulation FD Disclosure
Ticker: CNC · Form: 8-K · Filed: 2024-03-11T00:00:00.000Z
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: CNC
TL;DR
Centene filed an 8-K for a Reg FD disclosure on 3/11/24.
AI Summary
Centene Corporation filed an 8-K on March 11, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the disclosure itself, only that it is being made on this date.
Why It Matters
This filing indicates Centene Corporation is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Centene Corporation (company) — Registrant
- March 11, 2024 (date) — Date of Report
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that it is being made on March 11, 2024.
What is the purpose of a Regulation FD Disclosure?
A Regulation FD Disclosure is made to ensure that material information is broadly disseminated to the public, preventing selective disclosure to certain investors.
When was this 8-K filing submitted?
The 8-K filing was submitted on March 11, 2024.
What is Centene Corporation's principal executive office address?
Centene Corporation's principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.
What is Centene Corporation's IRS Employer Identification Number?
Centene Corporation's IRS Employer Identification Number is 42-1406317.
From the Filing
0001071739-24-000049.txt : 20240311 0001071739-24-000049.hdr.sgml : 20240311 20240311163021 ACCESSION NUMBER: 0001071739-24-000049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240311 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 24738454 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20240311.htm 8-K cnc-20240311 0001071739 false 0001071739 2024-03-11 2024-03-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE Centene Corporation will be presenting at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 8:00 a.m. EDT. During the presentation, the Company expects to reaffirm its previously issued 2024 adjusted diluted earnings per share (EPS) annual guidance of greater than $6.70. A simultaneous live audio webcast of the presentation on March 12 will be available at: https://event.webcasts.com/starthere.jsp?ei=1659141&tp_key=18b8362d5e&tp_special=8. A webcast replay will be available afterwards via the Company's website at www.centene.com, under the Investors section. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this Form 8-K as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nat